DIC - Nursing Case Study
Pathophysiology
• Primary mechanism: Disseminated Intravascular Coagulation (DIC) is triggered by the widespread activation of the coagulation cascade, often due to severe infection, trauma, or malignancy, leading to excessive thrombin generation and fibrin formation.
• Secondary mechanism: This overactive coagulation results in the consumption of platelets and coagulation factors, depleting the body’s reserves and causing widespread microvascular thrombi, which can impair organ function.
• Key complication: As the coagulation factors are exhausted, the body's ability to control bleeding diminishes, leading to a paradoxical increase in bleeding risk alongside the formation of clots, manifesting as both thrombosis and hemorrhage.
Patient Profile
Demographics:
56-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes, recent abdominal surgery
• Current medications: Lisinopril, Metformin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing bruising and bleeding from surgical incision site
• Key symptoms: Shortness of breath, fatigue, diffuse petechiae, oozing from gums
• Vital signs: Blood pressure 88/54 mmHg, heart rate 112 bpm, respiratory rate 24 breaths/min, temperature 38.3°C (100.9°F), oxygen saturation 91% on room air
Section 1
As the medical team continues to monitor the 56-year-old patient, several new diagnostic results provide further insight into his deteriorating condition. A complete blood count reveals thrombocytopenia, with platelet levels significantly reduced at 45,000/mm³, indicating substantial consumption of platelets consistent with DIC. Coagulation studies show prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), suggesting the depletion of clotting factors. Fibrin degradation products, including D-dimer, are markedly elevated, underscoring ongoing fibrinolysis and supporting the diagnosis of DIC.
Concurrently, a metabolic panel reveals acute kidney injury, with creatinine levels elevated to 2.1 mg/dL from a baseline of 1.0 mg/dL, reflecting possible renal microthrombi and impaired perfusion. The patient's liver function tests show increased transaminases, indicating hepatic stress or dysfunction. These findings suggest that the microvascular thrombi associated with DIC are beginning to compromise organ function, necessitating a comprehensive approach to manage both bleeding and thrombotic risks.
The patient's clinical status is further complicated by the development of respiratory distress. A chest X-ray indicates bilateral pulmonary infiltrates, raising concerns for acute respiratory distress syndrome (ARDS) secondary to the systemic inflammatory response and microvascular thrombosis in the lungs. Oxygen supplementation is increased to maintain adequate saturation, and the interdisciplinary team deliberates on the balance between anticoagulation to prevent further thrombotic events and transfusion strategies to address coagulopathy and bleeding risks. The focus now shifts to stabilizing the patient's condition while preventing further organ damage, highlighting the complexity of managing DIC with concurrent systemic complications.
Section 2
The medical team closely monitors the patient's respiratory status as his condition evolves. Despite increased oxygen supplementation, the patient shows signs of worsening respiratory distress, characterized by labored breathing, use of accessory muscles, and a persistent drop in oxygen saturation to 88% on high-flow nasal cannula. Auscultation reveals diminished breath sounds with crackles in both lung fields, indicative of fluid accumulation and potential progression of acute respiratory distress syndrome (ARDS). This development necessitates an urgent reassessment of the patient's ventilatory support needs, prompting consideration for intubation and mechanical ventilation to prevent further respiratory compromise.
Simultaneously, the patient's hemodynamic status becomes increasingly unstable. Blood pressure readings fluctuate, with episodes of hypotension noted at 85/50 mmHg, despite fluid resuscitation efforts. Tachycardia persists, with heart rates consistently elevated around 120 beats per minute. These signs of hemodynamic instability suggest that the microvascular thrombotic events are exacerbating systemic perfusion deficits, further straining the patient's already compromised organ systems. The interdisciplinary team discusses the potential initiation of vasopressor support to stabilize blood pressure while continuing to address the underlying pathophysiology of DIC.
In response to these critical changes, the medical team reviews the patient's coagulation profile to guide therapeutic decisions. Given the ongoing risk of both bleeding and thrombosis, a cautious approach to anticoagulation is considered, with low-molecular-weight heparin being discussed as a potential option, weighing the benefits against the risk of exacerbating bleeding. Concurrently, platelet transfusions and fresh frozen plasma are administered to correct coagulopathy and support clotting factor replenishment. This multifaceted management plan underscores the complexity of treating DIC amidst evolving systemic complications, as the team aims to stabilize the patient's condition and prevent further deterioration.
Section 3
New Complications:
As the medical team continues to manage the patient's condition, further complications arise that demand immediate attention. The patient's renal function begins to decline, as evidenced by a sudden increase in serum creatinine to 2.3 mg/dL from a baseline of 1.0 mg/dL, alongside a reduced urine output of less than 20 mL per hour over the past four hours. This acute kidney injury (AKI) is suspected to be multifactorial, with contributions from the ongoing disseminated intravascular coagulation (DIC), hemodynamic instability, and potential nephrotoxic effects of medications administered during resuscitation efforts. The interdisciplinary team recognizes the importance of addressing this renal impairment to prevent further complications. They consider implementing renal replacement therapy while optimizing fluid management to maintain perfusion without exacerbating pulmonary edema.
In addition to renal complications, the patient develops signs of gastrointestinal bleeding, presenting with hematemesis and melena. This alarming development underscores the precarious balance of managing DIC, as the risk of bleeding complicates the therapeutic strategy. The patient's hemoglobin level drops to 7.2 g/dL, prompting the need for blood transfusions to address acute anemia and ensure adequate oxygen-carrying capacity. Endoscopic evaluation is considered to identify and manage the source of bleeding, alongside the careful adjustment of anticoagulation therapy to prevent worsening thrombotic events.
These new complications highlight the intricate interplay of organ systems affected by DIC and necessitate vigilant monitoring and agile intervention by the healthcare team. As they work to stabilize the patient's condition, the team must continuously reassess and adapt the management plan to address the dynamic challenges posed by the evolving clinical picture.
Section 4
Change in Patient Status:
Despite the intensive interventions, the patient's condition takes a turn for the worse. Over the next 12 hours, the patient becomes increasingly hypotensive, with blood pressure readings dropping to 85/50 mmHg, despite aggressive fluid resuscitation and vasopressor support. The heart rate remains elevated at 120 beats per minute, indicating persistent tachycardia. Respiratory rate increases to 28 breaths per minute, and oxygen saturation fluctuates between 88-92% on high-flow oxygen therapy, raising concerns about impending respiratory compromise. Auscultation of the lungs reveals crackles bilaterally, suggesting fluid overload and possible pulmonary edema, a complication of both aggressive fluid management and worsening cardiac function.
Laboratory results further highlight the critical state of the patient. The lactate level rises to 4.5 mmol/L, indicating tissue hypoperfusion and escalating metabolic acidosis. Arterial blood gas analysis shows a pH of 7.28, PaCO2 of 32 mmHg, and HCO3 of 16 mEq/L, consistent with a mixed acid-base disturbance. The ongoing anemia is exacerbated by the gastrointestinal bleeding, with hemoglobin levels now at 6.8 g/dL, necessitating additional transfusions. Coagulation profiles reveal a further drop in platelet count to 30,000/µL, with prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), reflecting the deteriorating coagulopathy associated with DIC.
The healthcare team swiftly recognizes the need for reassessment of the treatment strategy. With the patient's hemodynamic instability and respiratory distress, the team considers implementing mechanical ventilation to support respiratory function and reduce metabolic demand. Concurrently, they reevaluate the balance between anticoagulation and bleeding risk, adjusting the therapeutic approach to stabilize coagulation parameters while managing the ongoing risk of hemorrhage. The team contemplates additional imaging and echocardiography to assess cardiac function and guide further interventions, recognizing the complexity of managing the intertwined complications of DIC, AKI, and multiorgan dysfunction.
Section 5
New Diagnostic Results:
In the wake of the patient's deteriorating condition, the healthcare team prioritizes additional diagnostic assessments to better understand the underlying causes of the rapid clinical decline. An urgent echocardiogram is performed, revealing severely reduced left ventricular ejection fraction at 30%, consistent with acute heart failure exacerbated by the systemic strain of sepsis and DIC. This finding corroborates the suspicion of worsening cardiac function, potentially contributing to the patient's refractory hypotension and pulmonary edema. Additionally, a chest X-ray is obtained, showing diffuse bilateral infiltrates, further indicating pulmonary congestion and edema.
Simultaneously, a repeat set of laboratory investigations is undertaken to reassess organ function and guide further management. The results show a continued rise in serum creatinine to 3.2 mg/dL, confirming acute kidney injury (AKI) progression likely secondary to ongoing hypoperfusion and possible nephrotoxicity. Liver function tests reveal elevated transaminases, with AST and ALT levels climbing to 250 IU/L and 300 IU/L, respectively, suggesting hepatic involvement. Furthermore, the patient's coagulation profile remains critically deranged, with D-dimer levels skyrocketing to over 10,000 ng/mL, indicating persistent activation of the coagulation cascade associated with severe DIC.
These diagnostic results prompt the healthcare team to consider a multi-faceted approach, including optimizing hemodynamic support with potential adjustments in vasopressor therapy and evaluating the need for renal replacement therapy in light of the worsening AKI. The cardiac dysfunction identified necessitates careful fluid management and possible initiation of inotropic support. The team recognizes the complexity of balancing these interventions to stabilize the patient's condition while mitigating further organ damage, underscoring the importance of continuous monitoring and reassessment in this critical phase of care.